239 related articles for article (PubMed ID: 31514236)
1. Venous thromboembolism prophylaxis of the obese postpartum patient: A cross-sectional study.
Gilmartin CE; Cutts BA; Ismail H
Aust N Z J Obstet Gynaecol; 2020 Jun; 60(3):376-381. PubMed ID: 31514236
[TBL] [Abstract][Full Text] [Related]
2. Venous thromboembolism, thrombophilia, antithrombotic therapy, and pregnancy: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).
Bates SM; Greer IA; Pabinger I; Sofaer S; Hirsh J
Chest; 2008 Jun; 133(6 Suppl):844S-886S. PubMed ID: 18574280
[TBL] [Abstract][Full Text] [Related]
3. Prophylaxis with low-dose low-molecular-weight heparin during pregnancy and postpartum: is it effective?
Roeters van Lennep JE; Meijer E; Klumper FJ; Middeldorp JM; Bloemenkamp KW; Middeldorp S
J Thromb Haemost; 2011 Mar; 9(3):473-80. PubMed ID: 21232006
[TBL] [Abstract][Full Text] [Related]
4. [Pharmacological Thromboprophylaxis during Pregnancy and the Puerperium: Recommendations from Current Guidelines and their Critical Comparison].
Rath W; Tsikouras P; von Tempelhoff GF
Z Geburtshilfe Neonatol; 2016 Jun; 220(3):95-105. PubMed ID: 27315397
[TBL] [Abstract][Full Text] [Related]
5. Low-molecular-weight heparin to prevent recurrent venous thromboembolism in pregnancy: Rationale and design of the Highlow study, a randomised trial of two doses.
Bleker SM; Buchmüller A; Chauleur C; Ní Áinle F; Donnelly J; Verhamme P; Jacobsen AF; Ganzevoort W; Prins M; Beyer-Westendorf J; DeSancho M; Konstantinides S; Pabinger I; Rodger M; Decousus H; Middeldorp S
Thromb Res; 2016 Aug; 144():62-8. PubMed ID: 27289488
[TBL] [Abstract][Full Text] [Related]
6. Compliance with the 2009 Royal College of Obstetricians and Gynaecologists guidelines for venous thromboembolic disease prophylaxis in pregnancy and postpartum period in Uruguay.
Grille S; Vitureira G; Morán R; Retamosa L; Alonso V; Gómez LM; Quartara F; Feldman F; López V; Turcatti P; Castro V; Sosa L; Guillermo C; Díaz L; Stevenazzi M
Blood Coagul Fibrinolysis; 2018 Apr; 29(3):252-256. PubMed ID: 29369082
[TBL] [Abstract][Full Text] [Related]
7. A local risk score model for venous thromboembolism prophylaxis for caesarean section in Chinese women and comparison with international guidelines.
Lok WY; Kong CW; To WWK
Taiwan J Obstet Gynecol; 2019 Jul; 58(4):520-525. PubMed ID: 31307744
[TBL] [Abstract][Full Text] [Related]
8. Postpartum thromboprophylaxis in a multireligious cohort: a retrospective review of indications and uptake.
Voon HY; Chai MC; Hii LY; Amin R; Suharjono HN
J Obstet Gynaecol; 2018 May; 38(4):493-497. PubMed ID: 29433369
[TBL] [Abstract][Full Text] [Related]
9. Risk Assessment Model for Postpartum Venous Thromboembolism Prevention in Patients with Systemic Lupus Erythematosus.
Griffin MM; Engel A; Mehta-Lee SS; Nusbaum J; Golpanian M; Izmirly P; Belmont HM; Buyon JP
Am J Perinatol; 2023 Dec; 40(16):1732-1737. PubMed ID: 37494484
[TBL] [Abstract][Full Text] [Related]
10. Venous Thromboembolism Prophylaxis During Antepartum Admissions and Postpartum Readmissions.
Mardy AH; Siddiq Z; Ananth CV; Wright JD; D'Alton ME; Friedman AM
Obstet Gynecol; 2017 Aug; 130(2):270-278. PubMed ID: 28697100
[TBL] [Abstract][Full Text] [Related]
11. The prevention of pregnancy-related venous thromboembolism.
Guimicheva B; Czuprynska J; Arya R
Br J Haematol; 2015 Jan; 168(2):163-74. PubMed ID: 25312482
[TBL] [Abstract][Full Text] [Related]
12. [Thromboprophylaxis during pregnancy and the puerperium: highlights from current guidelines].
Rath W
Z Geburtshilfe Neonatol; 2010 Dec; 214(6):217-28. PubMed ID: 21207321
[TBL] [Abstract][Full Text] [Related]
13. Implementation of thromboprophylaxis guidelines.
Cregan A; Higgins JR; O'Shea S
Ir Med J; 2013 Mar; 106(3):80-2. PubMed ID: 23951977
[TBL] [Abstract][Full Text] [Related]
14. United Kingdom recommendations for obstetric venous thromboembolism prophylaxis: Evidence and rationale.
Lamont MC; McDermott C; Thomson AJ; Greer IA
Semin Perinatol; 2019 Jun; 43(4):222-228. PubMed ID: 30935752
[TBL] [Abstract][Full Text] [Related]
15. Association between prophylactic low-molecular-weight heparin use in pregnancy and macrosomia: analysis of the Ottawa and Kingston birth cohort.
Lowry DE; Corsi DJ; White RR; Guo M; Lanes A; Smith G; Rodger M; Wen SW; Walker M; Gaudet L
J Thromb Haemost; 2019 Feb; 17(2):345-349. PubMed ID: 30552749
[TBL] [Abstract][Full Text] [Related]
16. A comparison of recommendations for pharmacologic thromboembolism prophylaxis after caesarean delivery from three major guidelines.
Palmerola KL; D'Alton ME; Brock CO; Friedman AM
BJOG; 2016 Dec; 123(13):2157-2162. PubMed ID: 26435300
[TBL] [Abstract][Full Text] [Related]
17. [Thromboprophylaxis with low-molecular-weight heparin insufficient in high-risk pregnancy].
Roeters van Lennep JE; Meijer E; Klumper FJ; Middeldorp JM; Bloemenkamp KW; Middeldorp S
Ned Tijdschr Geneeskd; 2011; 155():A3433. PubMed ID: 21527059
[TBL] [Abstract][Full Text] [Related]
18. Postpartum pharmacologic thromboprophylaxis and complications in a US cohort.
Bruno AM; Sandoval GJ; Hughes BL; Grobman WA; Saade GR; Manuck TA; Longo M; Metz TD; Simhan HN; Rouse DJ; Mendez-Figueroa H; Gyamfi-Bannerman C; Bailit JL; Costantine MM; Sehdev HM; Tita ATN;
Am J Obstet Gynecol; 2024 Jul; 231(1):128.e1-128.e11. PubMed ID: 38346912
[TBL] [Abstract][Full Text] [Related]
19. Effectiveness and safety of thromboprophylaxis with enoxaparin for prevention of pregnancy-associated venous thromboembolism.
Cox S; Eslick R; McLintock C
J Thromb Haemost; 2019 Jul; 17(7):1160-1170. PubMed ID: 31013386
[TBL] [Abstract][Full Text] [Related]
20. The incidence and risk factors of recurrent venous thromboembolism during pregnancy.
Galambosi PJ; Ulander VM; Kaaja RJ
Thromb Res; 2014 Aug; 134(2):240-5. PubMed ID: 24835671
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
